Loading...

Operating Data

Illumina Inc.

Illumina Inc. (ILMN)

Healthcare

Year
A/P
2013
Actual
2014
Actual
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 1,421.181,861.322,437.773,192.744,181.545,476.567,172.659,394.0212,303.3416,113.6921,104.10
Revenue (%)
EBITDA 296.88603.07649.66850.871,114.381,459.501,911.512,503.513,278.844,294.305,624.24
EBITDA (%)
EBIT 198.96490.46491.94644.30843.831,105.171,447.441,895.712,482.813,251.744,258.81
EBIT (%)
Depreciation 97.92112.61157.72206.57270.55354.33464.07607.79796.031,042.561,365.44
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)